ANTI-SARS-CoV-2 ANTIGEN BINDING POLYPEPTIDES, POLYPEPTIDE COMPLEXES AND METHODS OF USE THEREOF [COM4] Read more about ANTI-SARS-CoV-2 ANTIGEN BINDING POLYPEPTIDES, POLYPEPTIDE COMPLEXES AND METHODS OF USE THEREOF [COM4] US Application 63/381,850Filed on 2022-11-01
ANTI-SARS-CoV-2 ANTIGEN BINDING POLYPEPTIDES, POLYPEPTIDE COMPLEXES AND METHODS OF USE THEREOF [COM4] Read more about ANTI-SARS-CoV-2 ANTIGEN BINDING POLYPEPTIDES, POLYPEPTIDE COMPLEXES AND METHODS OF USE THEREOF [COM4] US Application 63/357,873Filed on 2022-07-01
ANTI-SARS-CoV-2 ANTIGEN BINDING POLYPEPTIDES, POLYPEPTIDE COMPLEXES AND METHODS OF USE THEREOF [COM4] Read more about ANTI-SARS-CoV-2 ANTIGEN BINDING POLYPEPTIDES, POLYPEPTIDE COMPLEXES AND METHODS OF USE THEREOF [COM4] US Application 63/357,336Filed on 2022-06-30
FORMULATION, STABILITY, PHARMACOKINETIC, AND MODELING STUDIES FOR TESTS OF SYNERGISTIC COMBINATIONS OF ORALLY AVAILABLE APPROVED DRUGS AGAINST EBOLA VIRUS IN VIVO Read more about FORMULATION, STABILITY, PHARMACOKINETIC, AND MODELING STUDIES FOR TESTS OF SYNERGISTIC COMBINATIONS OF ORALLY AVAILABLE APPROVED DRUGS AGAINST EBOLA VIRUS IN VIVO US Application 63/147,587Filed on 2021-02-09
Bispecific antibodies that broadly target coronaviruses Read more about Bispecific antibodies that broadly target coronaviruses US Application 63/528,158Filed on 2023-07-21
Self-Assembling Nanoparticles Read more about Self-Assembling Nanoparticles US Application 63/380,931Filed on 2022-10-25
HIV-1 Envelope Triple Tandem Trimers Read more about HIV-1 Envelope Triple Tandem Trimers US Application 63/469,773Filed on 2023-05-30
VACCINE FOR CATS TO BLOCK TOXOPLASMA OOCYST SHEDDING AND TRANSMISSION Read more about VACCINE FOR CATS TO BLOCK TOXOPLASMA OOCYST SHEDDING AND TRANSMISSION US Application 63/470,773Filed on 2023-06-02
Rebalancing the Immune System Through Depletion of Myeloid-Biased Hematopoietic Stem Cells Read more about Rebalancing the Immune System Through Depletion of Myeloid-Biased Hematopoietic Stem Cells US Application 63/422,765Filed on 2022-11-04
NOVEL MALARIA VACCINE COMPRISING AMA1 AND RON2 ANTIGENS Read more about NOVEL MALARIA VACCINE COMPRISING AMA1 AND RON2 ANTIGENS US Application 63/524,522Filed on 2023-06-30